Anest. intenziv. Med. 2000;11(5):206-210

Accelerometry for Detection of Residual Neuromuscular BlockadeArticles

M. Adamus
KAR FN a LF UP Olomouc, přednosta prim. MUDr. Oldřich Marek

We have compared two techniques of neuromuscular blockade monitoring, accelerometry and electromyography (ACC vs EMG). Neuromusculartransmission was measured using both EMG and ACC in 20 ASA I - III patients undergoing elect ive craniotomy in general anaesthesia longer thentwo hours. After suxamethonium administration (Ł 100 mg) to facilitate tracheal intubation, neuromuscular block was maintained by repeated bolusesof vecuronium (1 - 4 mg). Stimulation pattern consisted of TOF supramaximal stimuli (ulnar nerve) every 20 seconds, muscle response of the adductorpollicis was observed. 1218 paired measurements of TOF were obtained (TOFEMG and TOFACC). The average difference in TOF-ratio between EMGand ACC values showed bias of 0,3 % with standard deviation ± 8.7 %. The limits of agreement (range in which 95 % of the differences between pairedmeasurements are expected to lie) were from -17 to +17 %. The sensitivity of accelerometry to detect recovery from neuromuscular block (criterionof adequate recovery was TOF-ratio ł 70 %) reached 87 %, specificity 96 %. Both measurement techniques provided reliable information of degreeof neuromuscular block. Under the study conditions described, accelerometry (although it was not as accurate as electromyography) was able to detectresidual neuromuscular blockade.

Keywords: neuromuscular block; monitoring; acceleromyography; electromyography; neuromuscular blocking agents; vecuronium

Published: October 1, 2000  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Adamus M. Accelerometry for Detection of Residual Neuromuscular Blockade. Anest. intenziv. Med. 2000;11(5):206-210.
Download citation




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.